INBIOGEN Reports Outside Director Change, Appoints Seo Jung-seok and Accepts Resignation of Lee Geun-hwan, Board Composition Unchanged

INBIOGEN disclosed a change in outside directors effective June 30, 2026. Mr. Seo Jung-seok was newly appointed as an outside director, while Mr. Lee Geun-hwan resigned voluntarily due to personal reasons.
The total number of registered directors remains at 4 with 2 outside directors maintaining a 50% outside director ratio, indicating no significant shift in board structure.
The new director Mr. Seo is the representative lawyer of Samhyun Law Firm, expected to contribute independent decision-making based on legal expertise.
[AI Summary]This outside director change for INBIOGEN is a routine personnel adjustment with no direct impact on capital structure or shareholder value. The legal background of the new director may enhance governance transparency in the long term, but the short-term stock price effect is limited.